Folic acid The right dose

Canadian family physician Medecin de famille canadien (Impact Factor: 1.34). 12/2008; 54(11):1545-7.
Source: PubMed


ABSTRACTQUESTION The new Motherisk Guidelines suggest 5 mg/d of folic acid. Why was the dose increased? What is the time frame for taking such a dose?ANSWER Recent data from Ontario reveal that 40% of women of reproductive age still do not achieve therapeutic systemic levels of folate needed to prevent neural tube defects. Compliance is less than optimal among women using prenatal vitamins, rendering many women unprotected against neural tube defects. Taking a higher dose of folate will allow achievement of protective folate levels, even with partial compliance. Five mg of folate should be used daily several months before conception until the end of the first trimester.

Download full-text


Available from: Y. Ingrid Goh, May 16, 2014
25 Reads
  • Source
    • "Interestingly, Canada’s Motherisk program based in the Hospital for Sick Children, Ontario, recently changed its folic acid guidelines to 5mg/d for all women. This was after a recent study determined that 40% of Ontario women were not achieving optimally protective levels, despite fortification and supplementation [24]. Additionally, the 2007 guidelines from the Motherisk program and the Society of Obstetricians and Gynecologists of Canada call for 5mg/d for women with a variety of medical and social indications, including minority status, epilepsy, obesity, substance abuse, poor medication compliance, and lack of birth control [25]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This article presents data on the current best evidence-based clinical practices and controversies surrounding folic acid supplementation/fortification for the prevention of neural tube defects (NTDs) during early pregnancy. Formatted as a series of ten clinical questions, answers and extensive discussion are provided for each point. We assess the history and evidence behind supplementation and fortification, racial/ethnic disparities in NTDs on a global scale, and present information on risk factors for NTDs other than dietary folic acid deficiency. Also discussed are public health challenges, including disparities in NTD rates, population-wide monitoring of NTDs, and tracking safety data in the post-fortification era. Emerging data are also reviewed regarding the role folic acid may play in malignant processes, cardiovascular disease, male fertility, and other medical conditions.
    Journal of Experimental & Clinical Assisted Reproduction 08/2011; 8:2.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The effect of gestational multivitamin supplementation on the development of obesity in rat offspring fed an obesogenic diet was investigated. Pregnant Wistar rats (n=10 per group) were fed the AIN-93G diet with the recommended vitamin (RV) content or a 10-fold increase (high vitamin, HV). At weaning, 10 males and 10 females, from separate dams, and from each gestational diet group were weaned to the liquid obesogenic diet for 48 weeks post-weaning. Body weight (BW) was measured weekly, and food intake over 24 h was measured once every 3 weeks for 24 weeks. Every 4 weeks, after an overnight fast, food intake over 1 h was measured 30 min after a gavage of water or glucose. An oral glucose tolerance test (OGTT) was carried out every 3-5 weeks. Post-weaning fasting glucose, insulin, ghrelin, glucagon-like peptide 1 (GLP-1), and systolic blood pressure (SBP) were measured. No difference in BW at birth or litter size was observed. Males and females from HV dams gained 17% (P<0.05) and 37% (P<0.001) more BW at 48 weeks post-weaning, and consumed 18% (P=0.07) and 20% (P<0.05) more food. One-hour food intake after water and glucose preloads was 27% (P<0.01) and 34% (P<0.05) higher in males from HV dams. Fasting ghrelin and GLP-1 were 27 and 32% higher in males from HV dams at weaning (P<0.05). Blood glucose response to the OGTT was greater in both males and females from HV dams at 13 weeks post-weaning (P<0.05), and the insulin resistance index was 76 and 43% higher in females from HV dams at 14 and 28 weeks post-weaning (P<0.05). SBP was 23 and 16% higher at 44 weeks post-weaning in male and females (P<0.01). High multivitamin intake during pregnancy increases the phenotypic expression of obesity and components of the metabolic syndrome in both female and male rats fed an obesogenic diet.
    International journal of obesity (2005) 01/2009; 33(3):364-72. DOI:10.1038/ijo.2008.281 · 5.00 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Sodium valproate is a teratogen responsible for a wide range of abnormalities, including neural tube defects. It has traditionally been prescribed for epilepsy, but is increasingly used for such psychiatric conditions as bipolar disease. Women of childbearing age taking valproate should be warned of its teratogenicity and advised to plan pregnancies, take a higher dose of folate, discuss reducing the dose of valproate or changing the medication with their physician, and have antenatal screening. After birth, the infant should be examined for a wide range of reported abnormalities. Neurodevelopmental assessment should continue throughout childhood. We present a case that illustrates the need for better education of mothers taking valproate and the medical staff prescribing it.
    Neonatal network: NN 11/2009; 28(6):363-7. DOI:10.1891/0730-0832.28.6.363
Show more